Cynthia Hathaway is owner and managing patent attorney of Global Patent Group and specializes in global patent portfolio strategy and management in the pharmaceutical, biotechnological, and life sciences fields. Drawing on over 15 years’ experience, Cynthia supervises the firm’s patent attorneys, agents, and administrators in the preparation and prosecution of applications for United States and foreign filing, counseling of clients regarding patentability, freedom to operate, and drug patent life cycle management to minimize innovator and generic/biosimilar competition and maximize regulatory exclusivity, and providing IP transactional guidance to clients through licensing, financing, merger / acquisition, and joint development collaborations, including due diligence investigation and presentation. Cynthia’s clients have included pharmaceutical and biotech companies from start-ups to major pharma, as well as universities and private research institutes. Prior to joining Global Patent Group, Cynthia was an agent and intellectual property department liaison at Kalypsys, where she tactically managed the rapid growth of the patent estate and supported joint research programs with major pharmaceuticals partners.